NK cells trigger an anti-tumor immune response called antibody-dependant cellular cytotoxicity (ADCC) when activating receptors, such as CD16, attach to monoclonal antibodies (mAbs) on target cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results